[Pharmacological properties and clinical effects of the antifibrotic agent pirfenidone (Pirespa) for treatment of idiopathic pulmonary fibrosis].
Tokura
Takeshi
T
Oku
Hisashi
H
Tsukamoto
Yuuki
Y
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D010787:Photosensitivity Disorders / Q000139:chemically induced; D011728:Pyridones / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000139:chemically induced
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011728:Pyridones; C093844:pirfenidone